Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Sapey (Worcester, United Kingdom). Targeting neutrophils in asthma: a strategy shared with COPD?. Annual Congress 2012 - Are neutrophils a suitable target in severe asthma?

Member's Comments

No comment yet.

Related content which might interest you: What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 Targeting traits in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Eosinophils in COPD: do they predict drug response? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Neutrophils, airway hyperresponsiveness and COPD: true, true and related? Source: Eur Respir J 2012; 40: 1067-1069 Year: 2012 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Algorithm for identification of asthma–COPD overlap: consensus between the Spanish COPD and asthma guidelines Source: Eur Respir J, 49 (5) 1700068; 10.1183/13993003.00068-2017 Year: 2017 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Use of alternative therapies in patients with asthma and COPD: is there any difference? Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Mechanisms in COPD compared with asthma Source: Breathe 2008; 5: 134-144 Year: 2008 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015